Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Triple-Negative Invasive Breast Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02945579
What this trial is testing

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Who this might be right for
Estrogen Receptor NegativeHER2 Positive Breast CarcinomaHER2/Neu Negative+9 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Looking for participantsNCT04437160
What this trial is testing

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Who this might be right for
Triple Negative Breast Cancer
Chinese Academy of Medical Sciences 286
Early research (Phase 1)Ended earlyNCT04139993
What this trial is testing

RBX7455 Before Surgery for the Treatment of Operable Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Mayo Clinic 3
Testing effectiveness (Phase 2)Looking for participantsNCT04230109
What this trial is testing

Sacituzumab Govitecan In TNBC

Who this might be right for
Invasive Breast CancerTriple Negative Breast CancerER-Negative Breast Cancer+2 more
Massachusetts General Hospital 239
Large-scale testing (Phase 3)Looking for participantsNCT07679360
What this trial is testing

Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1,000
Not applicableStudy completedNCT05071677
What this trial is testing

Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
M.D. Anderson Cancer Center 30
Not applicableLooking for participantsNCT05877859
What this trial is testing

Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab

Who this might be right for
Breast Cancer Triple NegativeBreast Cancer Stage IIBreast Cancer Stage III+1 more
Emory University 10
Large-scale testing (Phase 3)Study completedNCT02620280
What this trial is testing

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

Who this might be right for
Invasive Ductal Breast Carcinoma
Fondazione Michelangelo 278
Testing effectiveness (Phase 2)Active Not RecruitingNCT05383196
What this trial is testing

Onvansertib + Paclitaxel In TNBC

Who this might be right for
Breast CancerInvasive Breast CancerUnresectable Breast Carcinoma+7 more
Antonio Giordano, MD 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04243616
What this trial is testing

Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer

Who this might be right for
Invasive Breast Cancer
Medical College of Wisconsin 36
Testing effectiveness (Phase 2)UnknownNCT02670109
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Who this might be right for
Triple-Negative Invasive Breast CarcinomaResidual Tumor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 20
Testing effectiveness (Phase 2)Study completedNCT02456857
What this trial is testing

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

Who this might be right for
Invasive Breast CarcinomaTriple-Negative Breast Carcinoma
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Looking for participantsNCT07188246
What this trial is testing

Neoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 40
Not applicableTemporarily pausedNCT04803084
What this trial is testing

Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment

Who this might be right for
Breast CancerTriple-negative Breast Cancer
Laura Kennedy 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03756298
What this trial is testing

Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
National Cancer Center, Korea 284
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Ended earlyNCT03979508
What this trial is testing

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more
Mayo Clinic 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03366844
What this trial is testing

Breast Cancer Study of Preoperative Pembrolizumab + Radiation

Who this might be right for
Breast Cancer
Stephen Shiao 66
Testing effectiveness (Phase 2)Study completedNCT01849250
What this trial is testing

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Who this might be right for
Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+9 more
National Cancer Institute (NCI) 65
Early research (Phase 1)WithdrawnNCT06590558
What this trial is testing

Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+9 more
National Cancer Institute (NCI)
Next Page